Ignite Creation Date:
2024-05-05 @ 4:51 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00327041
Status:
UNKNOWN
Last Update Posted:
2006-05-17
First Post:
2006-05-15
Brief Title:
Monitoring Response to Antiplatelet Therapy
Sponsor:
NHS Greater Glasgow and Clyde
Organization:
NHS Greater Glasgow and Clyde
Study Overview
Official Title:
Pilot Study Investigating the Use of a Variety of Assays to Detect Individual Response to Antiplatelet Therapy
Status:
UNKNOWN
Status Verified Date:
2006-05
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Antiplatelet therapy plays a key role in the prevention of complications related to coronary angioplasty and stenting PCI including procedure related myocardial damage Aspirin and clopidogrel are now universally prescribed in patients undergoing these procedures However loading and maintenance doses have not been established and variation in individual response is emerging New tests to assess the effects of these drugs are being developed but have yet to be incorporated into routine clinical practice We will assess the effects of aspirin and clopidogrel in a consecutive series of patients undergoing angioplasty using new assays which can be carried out at the bedside We will compare the results with alternative laboratory based tests and look for an association between the results peri-procedural myocardial necrosis and subsequent cardiovascular events
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None